Jazz Pharmaceuticals, Inc. (JAZZ) — Analysis Summary
Jazz Pharmaceuticals, Inc. (JAZZ) has a market cap of $14.84B with year-over-year revenue growth of +4.9%. Net margin stands at -8.3%. The stock trades at a P/E ratio of 503.1.
Key Takeaways
- Revenue changed +4.9% year-over-year
- Net margin of -8.3%
- P/E ratio of 503.1
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, JAZZ posted revenue growth of +4.9% and trades at a P/E of 503.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.